Valproic acid shows promise in reducing COVID-19 severity and hospitalization

Researchers found that valproic acid (VPA), especially when combined with DHA, significantly reduces SARS-CoV-2 infection rates and severity, potentially activating antiviral mechanisms. Epidemiologic data support VPA’s role in reducing COVID-19 severity and hospitalization rates.

Researchers sound a clarion call for greater investment in bereavement care

The public health toll from bereavement is well-documented in the medical literature, with bereaved persons at greater risk for many adverse outcomes, including mental health

March 15, 2024

HHS, vaccine makers prep for first-ever three-vaccine availability with Covid, flu and RSV ahead of peak viral season

Last fall’s virus tripledemic is giving way to this year’s three-vaccine season. And the Department of Health and Human Services says it is pulling out

August 26, 2023

AI uncovers potential cancer drivers hidden in ‘junk’ regions of DNA

Using artificial intelligence, Garvan Institute researchers have found potential cancer drivers hidden in so-called ‘junk’ regions of DNA, opening up possibilities for a new approach

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.